In a landmark development underscoring the global race for obesity treatments, US pharmaceutical giant Pfizer has secured a ten billion dollar takeover of Metsera. The deal follows an intense bidding
In a landmark development underscoring the global race for obesity treatments, US pharmaceutical giant Pfizer has secured a ten billion dollar takeover of Metsera. The deal follows an intense bidding






